• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 8, Issue 1
  3. Authors

Online ISSN: 2515-8260

Volume8, Issue1

Early Diagnosis of Breast Cancer by Detection of Genetic Variation for BRCA1 and BRCA2 Genes in the Women's of Nineveh Province

    Nada Saad Omer Dr.FİLİZ SARIKAYA PEKACAR Dr. HananShihab Ahmad

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 1, Pages 1525-1532

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Women's Breast Cancer ranks first among other type in Iraq and the world. It often detects because of
examinations performed in patients on familial cancer history. Approximately, 10% of hereditary breast cancer
represents of all breast cancer cases and BRCA1/2 represented the responsible genes. Mutations in the BRCA1/2
germ increases the risk of hereditary breast cancer twenty times more. Therefore, the detection of BRCA1/2
genes mutations is important for the diagnosis, treatment and application of clinical methods of patients. New
generation sequencing is more useful than classical methods. With this method, a patient-specific clinical
treatment can be customized, treatment, and early diagnosis, facilitates new discoveries, identification of existing
mutations, primarily breast and ovarian cancer.
In this study, the female patients had selected between the ages of 18-49 living in Nineveh-Iraq and having
demographic identical qualities, the samples taken within the consent of the participants were examined and
some significant mutations had been detected. Bioinformatics studies of variants evaluatedas pathogenic were
performed. In addition, variants of unknown clinical significance were identified and listed.Based on the results
obtained in the study, it is concluded that tests should be applied directly in the laboratory environment to
develop an understanding based on the Next Generation Sequencing approach for the detection of BRCA1 and
BRCA2 mutations and to evaluate the functional role of the mutations. In addition, our study draws a conclusion
for the early diagnosis of the New Generation Sequencing technique and the development of a personalized,
patient-specific treatment approach.
Keywords:
    BRCA1 BRCA2 next generation sequencing Breast Cancer Hereditary Breast Cancer
  • PDF (686 K)
  • XML
(2021). Early Diagnosis of Breast Cancer by Detection of Genetic Variation for BRCA1 and BRCA2 Genes in the Women's of Nineveh Province. European Journal of Molecular & Clinical Medicine, 8(1), 1525-1532.
Nada Saad Omer; Dr.FİLİZ SARIKAYA PEKACAR; Dr. HananShihab Ahmad. "Early Diagnosis of Breast Cancer by Detection of Genetic Variation for BRCA1 and BRCA2 Genes in the Women's of Nineveh Province". European Journal of Molecular & Clinical Medicine, 8, 1, 2021, 1525-1532.
(2021). 'Early Diagnosis of Breast Cancer by Detection of Genetic Variation for BRCA1 and BRCA2 Genes in the Women's of Nineveh Province', European Journal of Molecular & Clinical Medicine, 8(1), pp. 1525-1532.
Early Diagnosis of Breast Cancer by Detection of Genetic Variation for BRCA1 and BRCA2 Genes in the Women's of Nineveh Province. European Journal of Molecular & Clinical Medicine, 2021; 8(1): 1525-1532.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 167
  • PDF Download: 253
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus